{"version":"1.0","provider_name":"Institute of Global Health Innovation","provider_url":"https:\/\/blogs.imperial.ac.uk\/ighi","author_name":"Nikita Rathod","author_url":"https:\/\/blogs.imperial.ac.uk\/ighi\/author\/nrathod\/","title":"Cholangiocarcinoma - the rare disease that's on the increase - Institute of Global Health Innovation","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"CTDY0KZ8bB\"><a href=\"https:\/\/blogs.imperial.ac.uk\/ighi\/2018\/02\/28\/cholangiocarcinoma-rare-disease-thats-increase\/\">Cholangiocarcinoma &#8211; the rare disease that&#8217;s on the increase<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.imperial.ac.uk\/ighi\/2018\/02\/28\/cholangiocarcinoma-rare-disease-thats-increase\/embed\/#?secret=CTDY0KZ8bB\" width=\"600\" height=\"338\" title=\"&#8220;Cholangiocarcinoma &#8211; the rare disease that&#8217;s on the increase&#8221; &#8212; Institute of Global Health Innovation\" data-secret=\"CTDY0KZ8bB\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.imperial.ac.uk\/ighi\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"By Professor Simon Taylor-Robinson, Consultant Hepatologist and Professor of Translational Medicine at Imperial College London Cholangiocarcinoma is a rare primary malignancy arising from cholangiocytes, the endothelial lining of the biliary ducts, with an incidence 2500 cases of per annum in the UK. The only option for cure is surgical resection, but cholangiocarcinoma usually presents late [&hellip;]","thumbnail_url":"https:\/\/blogs.imperial.ac.uk\/ighi\/files\/2018\/02\/P5142439-300x200.jpg"}